Literature DB >> 30246459

Long noncoding RNA SNHG12 promotes the progression of cervical cancer via modulating miR-125b/STAT3 axis.

Xue-J Jin1, Xiang-J Chen2, Zhi-F Zhang1, Wen-S Hu1, Rong-Y Ou3, Shi Li4, Ji-S Xue3, Lu-L Chen3, Yan Hu3, Hua Zhu3.   

Abstract

Increasing evidence showed that long noncoding RNAs (lncRNAs) played an important role in the occurrence and development of tumors. To date, lncRNA small nucleolar RNA host gene 12 (SNHG12) has revealed an oncogenic role in various tumors. However, the role of SNHG12 in cervical cancer is still unclear. Therefore, we focused on the biological function and molecular mechanism of SNHG12 in the tumorigenesis of cervical cancer. In this study, the expression of miR-125b was observably downregulated in cervical cancer cells. Meanwhile, the expression of SNHG12 was obviously upregulated in cervical cancer cell lines (HeLa, SiHa, Caski, C4-1, and C33A) compared with the immortalized cervical epithelial cells. The further assay showed that miR-125b was a target of SNHG12 in cervical cancer. Moreover, a negative relationship between miR-125b and SNHG12 was found in cervical cancer. In addition, SNHG12 inhibition restrained the proliferation, migration, and invasion of cervical cancer cells. Meanwhile, miR-125b mimics repressed the expression of signal transducer and activator of transcription 3 (STAT3). The further assay showed that STAT3 was a target of miR-125b in cervical cancer. In addition, sh-STAT3 repressed the migration and invasion of cervical cancer cells. Furthermore, it showed that miR-125b inhibitors reversed STAT3 expression restrained by the reduction of SNHG12 expression. In general, SNHG12 modulated STAT3 by sponging miR-125b in cervical cancer and played an important role in the development of cervical cancer.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  cervical cancer; miR-125b; signal transducer and activator of transcription 3 (STAT3); small nucleolar RNA host gene 12 (SNHG12)

Mesh:

Substances:

Year:  2018        PMID: 30246459     DOI: 10.1002/jcp.27403

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  17 in total

Review 1.  Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: A review.

Authors:  Javid Sadri Nahand; Mohsen Moghoofei; Arash Salmaninejad; Zahra Bahmanpour; Mohammad Karimzadeh; Mitra Nasiri; Hamid Reza Mirzaei; Mohammad Hossein Pourhanifeh; Farah Bokharaei-Salim; Hamed Mirzaei; Michael R Hamblin
Journal:  Int J Cancer       Date:  2019-10-31       Impact factor: 7.396

2.  A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming.

Authors:  Hassan Yousefi; Maninder Khosla; Lothar Lauterboeck; Samuel C Okpechi; David Worthylake; Jone Garai; Jovanny Zabaleta; Jessie Guidry; Mohammad Amin Zarandi; Dorota Wyczechowska; Janarthanan Jayawickramarajah; Qinglin Yang; Joseph Kissil; Suresh K Alahari
Journal:  Oncogene       Date:  2022-10-15       Impact factor: 8.756

3.  Comprehensive Analysis of circRNA-miRNA-mRNA Network in Cervical Squamous Cell Carcinoma by Integrated Analysis.

Authors:  Qiongwei Wu; Ping Liu; Guoying Lao; Yu Liu; Wenying Zhang; Chengbin Ma
Journal:  Onco Targets Ther       Date:  2020-08-25       Impact factor: 4.147

4.  Long noncoding RNA LINC00460 promotes the progression of cervical cancer via regulation of the miR-361-3p/Gli1 axis.

Authors:  Fan Li; Weipei Zhu; Zhijie Wang
Journal:  Hum Cell       Date:  2020-10-16       Impact factor: 4.374

5.  Long Noncoding RNA SNHG12 Indicates the Prognosis and Accelerates Tumorigenesis of Diffuse Large B-Cell Lymphoma Through Sponging microR-195.

Authors:  Li-Yan Chen; Xiao-Min Zhang; Bi-Qing Han; Hai-Bin Dai
Journal:  Onco Targets Ther       Date:  2020-06-12       Impact factor: 4.147

6.  A frequent somatic mutation in the 3'UTR of GAPDH facilitates the development of ovarian cancer by creating a miR‑125b binding site.

Authors:  Peisen Liu; Yumin Zhong; Ting Cao; Xiujie Sheng; Huang Huang
Journal:  Oncol Rep       Date:  2020-06-25       Impact factor: 3.906

7.  Long non‑coding RNA SNHG12 regulates cell proliferation, invasion and migration in endometrial cancer by targeting miR‑4429.

Authors:  Pengyu Cai; Mingxiu Wu; Bin Zhang; Shuyi Wu; Haiyun Wei; Li Wei
Journal:  Mol Med Rep       Date:  2020-07-28       Impact factor: 2.952

8.  Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.

Authors:  Chenghao Zhang; Xiaolei Ren; Wenchao Zhang; Lile He; Lin Qi; Ruiqi Chen; Chao Tu; Zhihong Li
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

9.  LncRNA SNHG12 regulates ox-LDL-induced endothelial cell injury by the miR-218-5p/IGF2 axis in atherosclerosis.

Authors:  Ping Mao; Xiaowei Liu; Yingzheng Wen; Lijiang Tang; Yimin Tang
Journal:  Cell Cycle       Date:  2021-07-27       Impact factor: 5.173

10.  Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1.

Authors:  Duoguang Wu; Xiaotian He; Wenjian Wang; Xueting Hu; Kefeng Wang; Minghui Wang
Journal:  Mol Oncol       Date:  2020-06-18       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.